HR 6103 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To prohibit reductions in the workforce at the Drug Enforcement Administration, and for other purposes.
Summary
This bill prohibits the Drug Enforcement Administration from reducing the size of its laboratory workforce. The laboratory workforce, which includes forensic chemists, fingerprint specialists, digital forensic examiners, and other forensic laboratory positions, is exempt from hiring freezes or workforce reductions resulting from spending cuts or fund reprogramming. The bill also protects positions at other DEA locations that are designated to be relocated to forensic laboratories currently under construction. The bill does not restrict the Attorney General's authority to discipline or remove employees for misconduct or poor performance.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Rep. Pappas, Chris [D-NH-1] (D-NH)
1 cosponsor
- Rep. Bacon, Don [R-NE-2] (R-NE)
Actions (2)
- Nov 18, 2025 Referred to the House Committee on the Judiciary. · house
- Nov 18, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
November 18, 2025
Mr. Pappas (for himself and Mr. Bacon) introduced the following bill; which was referred to the Committee on the Judiciary
A BILL
To prohibit reductions in the workforce at the Drug Enforcement Administration, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Laboratory Analysts and Biometric Personnel Act of 2025” or the “LAB Personnel Act of 2025”.
SEC. 2. PROHIBITION ON REDUCING THE LABORATORY WORKFORCE AT THE DRUG ENFORCEMENT AGENCY.
(a) In General.—The laboratory workforce at the Drug Enforcement Administration shall be exempt from any hiring freezes or workforce reductions related to spending cuts, reprogramming of funds, or the probationary status of employees.
(b) Laboratory Workforce at the Drug Enforcement Administration Defined.—In this section, the term “laboratory workforce at the Drug Enforcement Administration” means—
(1) positions in the Drug Enforcement Administration at forensic laboratories of the Drug Enforcement Administration, including—
(A) forensic chemists;
(B) fingerprint specialists;
(C) digital forensic examiners; and
(D) any other positions in the Drug Enforcement Administration at such forensic laboratories; and
(2) other positions in the Drug Enforcement Administration at locations other than such a forensic laboratory that will be relocated to such a forensic laboratory that, as of the date of the enactment of this Act, is being constructed or otherwise finalized.
(c) Rule of Construction.—Nothing in this section may be construed to restrict the authority of the Attorney General to manage the workforce of the Department of Justice under existing procedures in cases of misconduct or poor performance. <all>
Comments